Covid-19: Gilead withdraws orphan drug designation from potential treatment after criticism

British Medical Journal

In rare move, Gilead gives up ‘orphan’ status for experimental coronavirus drug

BioPharma Drive

Partner with us now to build
a more just and equitable
medicine system for all.